Cell signalling of the GLP-1 action in rat liver

被引：82

作者：

Redondo, A ^{[1
]}

Trigo, MV ^{[1
]}

Acitores, A ^{[1
]}

Valverde, I ^{[1
]}

Villanueva-Peñacarrillo, ML ^{[1
]}

机构：

[1] Fdn Jimenez Diaz, Dept Metab Nutr & Hormones, E-28040 Madrid, Spain

来源：

MOLECULAR AND CELLULAR ENDOCRINOLOGY | 2003年 / 204卷 / 1-2期

关键词：

rat hepatocyte; glycogen synthase a; PI3K; PKC; MAPKs;

D O I：

10.1016/S0303-7207(03)00146-1

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

GLP-1, incretin with insulin-independent antidiabetic properties, is insulinomimetic upon glucose metabolism in extrapancreatic tissues, acting through specific receptors not associated to adenylate cyclase activation. We investigated the role of enzymes mediating insulin actions, in the GLP-1-induced glycogen synthase a activation in rat hepatocytes. GLP-1, like insulin, activates PI3K/PKB, p70s6k, p44 and p42 MAP-kinase. Wortmannin (PI3K/PKB inhibitor) blocked the stimulatory action of insulin on glycogen synthase a and reduced that of GLP-1; rapamycin (p70s6k inhibitor) was ineffective and PD98059 (MEK/MAPK inhibitor) decreased only the insulin effect; okadaic acid (PP-2A inhibitor) was ineffective, while TNFalpha (PP-1 inhibitor) blocked the action of insulin and reduced that of GLP-1; H-7 or Ro 31-8220 (PKC inhibitors) decreased the GLP-1 effect, while only H-7 reduced that of insulin. The activation of PI3K/PKB, PKC and PP-1, but not PP-2A, seems to mediate the GLP-1 stimulatory action on glycogen synthase a in rat hepatocytes, while MAPKs and p70s6k could participate in other GLP-1 effects. (C) 2003 Elsevier Science B.V. All rights reserved.

引用

页码：43 / 50

页数：8

共 48 条

[1]

Azpiazu I, 1996, J BIOL CHEM, V271, P5033

[2]

BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[3] Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells [J].

Buteau, J ;

Roduit, R ;

Susini, S ;

Prentki, M .

DIABETOLOGIA, 1999, 42 (07) :856-864

[4] Protein kinase Cζ activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation [J].

Buteau, J ;

Foisy, S ;

Rhodes, CJ ;

Carpenter, L ;

Biden, TJ ;

Prentki, M .

DIABETES, 2001, 50 (10) :2237-2243

[5]

Combettes-Souverain M, 1998, DIABETES METAB, V24, P477

[6] ENTERAL ENHANCEMENT OF GLUCOSE DISPOSITION BY BOTH INSULIN-DEPENDENT AND INSULIN-INDEPENDENT PROCESSES - A PHYSIOLOGICAL-ROLE OF GLUCAGON-LIKE PEPTIDE-I [J].

DALESSIO, DA ;

PRIGEON, RL ;

ENSINCK, JW .

DIABETES, 1995, 44 (12) :1433-1437

[7] Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].

Davies, SP ;

Reddy, H ;

Caivano, M ;

Cohen, P .

BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105

[8] GLUCAGON-LIKE PEPTIDE-1 BINDING TO RAT SKELETAL-MUSCLE [J].

DELGADO, E ;

LUQUE, MA ;

ALCANTARA, A ;

TRAPOTE, MA ;

CLEMENTE, F ;

GALERA, C ;

VALVERDE, I ;

VILLANUEVAPENACARRILLO, ML .

PEPTIDES, 1995, 16 (02) :225-229

[9] GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE (GLP-1) ENHANCES INSULIN-STIMULATED GLUCOSE-METABOLISM IN 3T3-L1 ADIPOCYTES - ONE OF SEVERAL POTENTIAL EXTRAPANCREATIC SITES OF GLP-1 ACTION [J].

EGAN, JM ;

MONTROSERAFIZADEH, C ;

WANG, YH ;

BERNIER, M ;

ROTH, J .

ENDOCRINOLOGY, 1994, 135 (05) :2070-2075

[10]

Galera C, 1996, CELL BIOCHEM FUNCT, V14, P43, DOI 10.1002/(SICI)1099-0844(199603)14:1<43::AID-CBF639>3.0.CO

← 1 2 3 4 5 →